Reliability and validity of the Chinese version of the addiction severity index.

Reliability and Validity of the Turkish Version of the Addiction Severity Index in Male Alcohol Dependents. Noro Psikiyatr Ars (2014) 0.75

Psychoactive Substance Use among Methadone Maintenance Therapy Clients in China. Int J Ment Health Addict (2017) 0.75

The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis (1980) 14.25

New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis (1985) 9.12

The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction (1998) 3.41

Studies of the reliability and validity of the Addiction Severity Index. Addiction (2004) 1.93

The Addiction Severity Index: a field study of internal consistency and validity. J Subst Abuse Treat (2000) 1.82

Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction (2000) 1.46

Initial validation of a computer-administered Addiction Severity Index: the ASI-MV. Psychol Addict Behav (2001) 1.40

Predictive validity of the Addiction Severity Index's composite scores in the assessment of 2-year outcomes in a methadone maintenance population. Psychol Addict Behav (2001) 1.38

The Addiction Severity Index: reliability and validity in a Dutch addict population. J Subst Abuse Treat (1989) 1.33

More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis (1992) 1.32

Use of the Addiction Severity Index with homeless substance abusers. J Subst Abuse Treat (1994) 1.17

Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Ment Health J (1997) 1.05

Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol (2000) 1.04

Conversion and validation of the Teen-Addiction Severity Index (T-ASI) for Internet and automated-telephone self-report administration. Psychol Addict Behav (2005) 1.00

Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population. J Nerv Ment Dis (1997) 0.96

French version of the addiction severity index (5th Edition): validity and reliability among Swiss opiate-dependent patients. French validation of the Addiction Severity Index. Eur Addict Res (2004) 0.94

Assessing the needs of substance abusing women. Psychometric data on the psychosocial history. J Subst Abuse Treat (1999) 0.87

Reliability and validity of the Hungarian version of the European Addiction Severity Index. Psychopathology (2005) 0.81

Emergence and control of infectious diseases in China. Lancet (2008) 5.93

Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS (2007) 3.18

Rapid scale up of harm reduction in China. Int J Drug Policy (2007) 2.92

HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis (2013) 2.82

Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol (2010) 2.65

The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr (2010) 2.61

Using case vignettes to measure HIV-related stigma among health professionals in China. Int J Epidemiol (2006) 2.57

Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis (2005) 2.47

HIV/STD stigmatization fears as health-seeking barriers in China. AIDS Behav (2006) 2.37

Acceptance of and barriers to voluntary HIV counselling and testing among adults in Guizhou province, China. AIDS (2007) 2.35

HIV-related stigma in health care settings: a survey of service providers in China. AIDS Patient Care STDS (2007) 2.25

Sexually transmitted disease prevalence and characteristics of market vendors in eastern China. Sex Transm Dis (2003) 2.02

Estimating the number of people living with HIV/AIDS in China: 2003-09. Int J Epidemiol (2010) 1.96

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85

Understanding HIV-related stigma and discrimination in a "blameless" population. AIDS Educ Prev (2006) 1.78

HIV/STD prevalence among men who have sex with men in Chengdu, China and associated risk factors for HIV infection. J Acquir Immune Defic Syndr (2010) 1.76

Evolution of men who have sex with men community and experienced stigma among men who have sex with men in Chengdu, China. J Acquir Immune Defic Syndr (2010) 1.72

A five-city trial of a behavioural intervention to reduce sexually transmitted disease/HIV risk among sex workers in China. AIDS (2007) 1.72

Understanding family support for people living with HIV/AIDS in Yunnan, China. AIDS Behav (2006) 1.71

Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol (2010) 1.71

A transcriptomic analysis of superhybrid rice LYP9 and its parents. Proc Natl Acad Sci U S A (2009) 1.67

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS (2010) 1.66

Development of a unified web-based national HIV/AIDS information system in China. Int J Epidemiol (2010) 1.65

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64

Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol (2010) 1.61

Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. AIDS (2007) 1.46

A brief HIV stigma reduction intervention for service providers in China. AIDS Patient Care STDS (2008) 1.41

Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS (2012) 1.40

Disclosure of HIV status is a family matter: field notes from China. J Fam Psychol (2007) 1.38

Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol (2012) 1.37

China AIDS policy implementation: reversing the HIV/AIDS epidemic by 2015. Int J Epidemiol (2010) 1.35

Sexual risk behaviors and HIV infection among men who have sex with men who use the internet in Beijing and Urumqi, China. J Acquir Immune Defic Syndr (2010) 1.34

Depression and suicidality in HIV/AIDS in China. J Affect Disord (2006) 1.32

Internet-facilitated, voluntary counseling and testing (VCT) clinic-based HIV testing among men who have sex with men in China. PLoS One (2013) 1.32

Reducing HIV-related stigma in health care settings: a randomized controlled trial in China. Am J Public Health (2012) 1.32

Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J Subst Abuse Treat (2009) 1.31

Assessing the efficacy of a voluntary HIV counseling and testing intervention for pregnant women and male partners in Urumqi City, China. AIDS Behav (2006) 1.30

Correlates of HIV infection among former blood/plasma donors in rural China. AIDS (2006) 1.29

Prevalence of HIV and STIs and associated risk factors among female sex workers in Guangdong Province, China. J Acquir Immune Defic Syndr (2010) 1.29

A method of finding optimal weight factors for compound identification in gas chromatography-mass spectrometry. Bioinformatics (2012) 1.27

HIV prevention intervention to reduce HIV-related stigma: evidence from China. AIDS (2010) 1.27

Challenges in providing services in methadone maintenance therapy clinics in China: service providers' perceptions. Int J Drug Policy (2009) 1.22

Survey on HIV/AIDS-related high risk behaviors among male sex workers in two cities in China. AIDS (2007) 1.21

Universal precautions in the era of HIV/AIDS: perception of health service providers in Yunnan, China. AIDS Behav (2007) 1.21

Sociocultural contexts and communication about sex in China: informing HIV/STD prevention programs. AIDS Educ Prev (2009) 1.19

Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy (2008) 1.16

A survey of condom use behaviors and HIV/STI prevalence among venue-based money boys in Shenzhen, China. AIDS Behav (2012) 1.15

HIV-related high-risk behaviors among Chinese migrant construction laborers in Nantong, Jiangsu. PLoS One (2012) 1.15

An evaluation of needle exchange programmes in China. AIDS (2007) 1.15

Mandatory HIV testing in China: the perception of health-care providers. Int J STD AIDS (2007) 1.13

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc (2007) 1.12

Occupational exposure to HIV among health care providers: a qualitative study in Yunnan, China. J Int Assoc Physicians AIDS Care (Chic) (2007) 1.12

APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS (2010) 1.12

Visiting entertainment venues and sexual health in China. Arch Sex Behav (2008) 1.11

Alcohol and drug use disorders among adults in emergency department settings in the United States. Ann Emerg Med (2012) 1.11

HIV-related stigma among market workers in China. Health Psychol (2005) 1.11

Institutional support for HIV/AIDS care in China: a multilevel analysis. AIDS Care (2008) 1.08

Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr (2010) 1.07

Individual attitudes and perceived social norms: Reports on HIV/AIDS-related stigma among service providers in China. Int J Psychol (2009) 1.07

Impacts of HIV/AIDS Stigma on Family Identity and Interactions in China. Fam Syst Health (2008) 1.06

Mass media and HIV/AIDS in China. J Health Commun (2009) 1.06

Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. J Proteome Res (2012) 1.06

Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One (2013) 1.05

Needle and syringe programs in Yunnan, China yield health and financial return. BMC Public Health (2011) 1.05

Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Subst Use Misuse (2011) 1.05

Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition. PLoS One (2011) 1.04

Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services. Bull World Health Organ (2013) 1.01

HIV among plasma donors and other high-risk groups in Henan, China. J Acquir Immune Defic Syndr (2010) 1.01

Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res (2010) 1.00

To tell or not to tell: HIV disclosure to family members in China. Dev World Bioeth (2008) 0.99

Quality of life of children living in HIV/AIDS-affected families in rural areas in Yunnan, China. AIDS Care (2010) 0.99

Popular Opinion Leader intervention for HIV stigma reduction in health care settings. AIDS Educ Prev (2013) 0.99

Stigmatizing attitudes and behaviors toward PLHA in rural China. AIDS Care (2010) 0.98

Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities. J Med Chem (2011) 0.97

HIV prevalence among pulmonary tuberculosis patients in Guangxi, China. J Acquir Immune Defic Syndr (2010) 0.97

Quantitatively monitoring AIDS policy implementation in China. Int J Epidemiol (2010) 0.96

A pilot intervention to increase condom use and HIV testing and counseling among men who have sex with men in Anhui, China. J Acquir Immune Defic Syndr (2010) 0.95

A comparison of voluntary counseling and testing uptake between a China CARES county and a county not designated for the china CARES program. AIDS Patient Care STDS (2008) 0.94

Molecular cloning and expression analysis of a monosaccharide transporter gene OsMST4 from rice (Oryza sativa L.). Plant Mol Biol (2007) 0.93

Identification of a glyphosate-resistant mutant of rice 5-enolpyruvylshikimate 3-phosphate synthase using a directed evolution strategy. Plant Physiol (2005) 0.93

Self-reported sexually transmitted disease symptoms and treatment-seeking behaviors in China. AIDS Patient Care STDS (2009) 0.92

Providers' HIV-related avoidance attitude and patient satisfaction. Health Expect (2011) 0.92

An ultrahigh affinity d-peptide antagonist Of MDM2. J Med Chem (2012) 0.90

Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer (2014) 0.90

LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release (2011) 0.89

[Qualitative study of drug-using and sexual behaviors of drug users in Guangxi]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 0.89

HIV epidemic among drug users in China: 1995-2011. Addiction (2015) 0.89

Diffusion of positive AIDS care messages among service providers in China. AIDS Educ Prev (2007) 0.89

Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China. Bull World Health Organ (2013) 0.89

Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1). Mol Cancer Ther (2009) 0.88

Syndromic and laboratory diagnosis of sexually transmitted infection: a comparative study in China. Int J STD AIDS (2008) 0.88

HIV-related avoidance and universal precaution in medical settings: opportunities to intervene. Health Serv Res (2010) 0.88

Implementing a stigma reduction intervention in healthcare settings. J Int AIDS Soc (2013) 0.88

Economic stress and HIV-associated health care utilization in a rural region of China: a qualitative study. AIDS Patient Care STDS (2007) 0.87

Comparison of GC-MS and GC×GC-MS in the analysis of human serum samples for biomarker discovery. J Proteome Res (2015) 0.86

Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies. Sex Transm Dis (2009) 0.86

Demographic and behavioral factors associated with HIV testing in China. J Acquir Immune Defic Syndr (2009) 0.86

HIV and syphilis prevalence trends among men who have sex with men in Guangxi, China: yearly cross-sectional surveys, 2008-2012. BMC Infect Dis (2014) 0.86

Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther (2008) 0.86